From: Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor
Side Effects
No of Patients
Wt Gain
6
Pigmentation
4
Rashes
Hepatotoxicity
9
Swelling
Myelosuppresion
31
Nausea
5
Gum bleeding
3
Vomiting
Mild arthralgia
2
Diarrhea
Others